Time New York: Sun 04 Dec 05:14 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Protalix BioTherapeutics (PLX) Jumps: Stock Rises 14.3%

Zacks

Protalix BioTherapeutics, Inc. PLX was a big mover last session, as its shares rose a little over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of 41 cents to 55 cents in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Recro Pharma currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

PROTALIX BIOTHR Price


PROTALIX BIOTHR Price | PROTALIX BIOTHR Quote

A better-ranked stock in the medical-biomedical and genetics space is Vanda Pharmaceuticals Inc. VNDA, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PLX going up? Or down? Predict to see what others think: Up or Down

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.